Cardinal Health (CAH) EPS (Weighted Average and Diluted) (2009 - 2026)

Cardinal Health has disclosed EPS (Weighted Average and Diluted) across 18 years of filings, most recently posting $1.69 for Q1 2026.

• EPS (Weighted Average and Diluted) for Q1 2026 came in at $1.69, down 19.52% year-over-year; the trailing twelve-month figure through Mar 2026 was $6.55 (up 2.34% YoY), and the FY2025 annual result was $6.45, up 86.96% from the prior year.
• EPS (Weighted Average and Diluted) came in at $1.69 for Q1 2026 at Cardinal Health, down from $1.97 in the prior quarter.
• In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $2.1 in Q1 2025 to a low of -$5.05 in Q1 2022.
• The 5-year median for EPS (Weighted Average and Diluted) is $1.07 (2024), against an average of $0.73.
• Across the five-year window, EPS (Weighted Average and Diluted) sank 1362.5% in 2022 and soared 3500.0% in 2024, its largest moves.
• Cardinal Health's EPS (Weighted Average and Diluted) stood at -$0.3 in 2022, then soared by 593.33% to $1.48 in 2023, then gained by 11.49% to $1.65 in 2024, then rose by 19.39% to $1.97 in 2025, then slipped by 14.21% to $1.69 in 2026.
• The last three EPS (Weighted Average and Diluted) figures came in at $1.69 (Q1 2026), $1.97 (Q4 2025), and $1.88 (Q3 2025), per Business Quant data.